Statement on HHS' New Guidelines Removing Barriers From Doctors to Prescribe Life-Saving Medication for Opioid Use Disorder
January 16, 2021
January 16, 2021
NEW YORK, Jan. 16 -- The Drug Policy Alliance issued the following statement:
* * *
In response to the U.S. Department of Health and Human Services' release of new practice guidelines that will allow DEA-registered physicians to prescribe buprenorphine without obtaining an X waiver, Kellen Russoniello, Senior Staff Attorney for the Drug Policy Alliance, released the following statement:
"With overdose deaths at record levels and continuing to increase . . .
* * *
In response to the U.S. Department of Health and Human Services' release of new practice guidelines that will allow DEA-registered physicians to prescribe buprenorphine without obtaining an X waiver, Kellen Russoniello, Senior Staff Attorney for the Drug Policy Alliance, released the following statement:
"With overdose deaths at record levels and continuing to increase . . .